DeAngelo, D J
Stevenson, K E
Dahlberg, S E
Silverman, L B
Couban, S
Supko, J G
Amrein, P C
Ballen, K K
Seftel, M D
Turner, A R
Leber, B
Howson-Jan, K
Kelly, K
Cohen, S
Matthews, J H
Savoie, L
Wadleigh, M
Sirulnik, L A
Galinsky, I
Neuberg, D S
Sallan, S E
Stone, R M
Article History
Received: 3 March 2014
Revised: 24 June 2014
Accepted: 17 July 2014
First Online: 31 July 2014
Competing interests
: DJDA has received honoraria for speaking engagements from Sigma Tau. LBS has received honoraria for serving on advisory boards for Sigma Tau and EUSA. JGS has received research support from Sigma Tau Research Inc. and EUSA Pharma (US) Inc. LAS has received honoraria for speaking engagements from Sigma Tau and Celgene. SES has received research support honoraria for speaking engagements from Sigma Tau, and consulted for Jazz Pharmaceuticals. The remaining authors declare no conflict of interest.